A drug in Stage 2 clinical trial seems to slow or stop the progression of IPF.
The Shaw Foundation in Hong Kong has announced that the renowned UW Medicine researcher will receive the 2018 Shaw Prize in the Life Sciences and Medicine for her pioneering work in breast cancer genetics.
Cardiologist's five-minute questionnaire identifies people at risk for atrial fibrillation and stroke.
Joseph Beavo's research has led to therapies for heart failure, prostate enlargement, and pulmonary hypertension.
A commentary in Science argues for more consideration of indigenous peoples' desires in the analysis of ancient remains.
Case in point: A drug for cancer was found to extend lives of people with progeria, and may have broader use in cardiovascular health.
As syphilis patient cases increase, so, too, do related cases of hearing loss and tinnitus.
A National Institutes of Health grant is funding 20 researchers at 12 U.S. sites.
A UW Medicine otolaryngologist discusses how the disease might affect the singer.
Q&A: Fewer procedures today than in 2008 and regional variation are among study findings.